Data move Endologix' AAA (abdominal aortic aneurysms) graft closer to France
This article was originally published in Clinica
Executive Summary
Endologix has moved a step closer to commercialising in France its PowerLink endoluminal stent graft (ELG) for treating of abdominal aortic aneurysms (AAAs), following positive trial results. In addition, says the company, two-year data from a separate trial are now available to support the product as a treatment for the condition.